| Exploiting the enhanced permeability and retention effect for tumor targeting AK Iyer, G Khaled, J Fang, H Maeda Drug discovery today 11 (17-18), 812-818, 2006 | 2233 | 2006 |
| PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers in pharmacology 8, 561, 2017 | 1711 | 2017 |
| siRNA delivery strategies: a comprehensive review of recent developments K Tatiparti, S Sau, SK Kashaw, AK Iyer Nanomaterials 7 (4), 77, 2017 | 491 | 2017 |
| Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery P Kesharwani, AK Iyer Drug discovery today 20 (5), 536-547, 2015 | 374 | 2015 |
| Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors S Ganesh, AK Iyer, DV Morrissey, MM Amiji Biomaterials 34 (13), 3489–3502, 2013 | 368 | 2013 |
| Role of Integrated Cancer Nanomedicine in Overcoming Drug Resistance A Iyer, A Singh, M Ganta, Srinivas, Amiji Advanced Drug Delivery Reviews, 2013 | 363 | 2013 |
| PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery D Luong, P Kesharwani, R Deshmukh, MCIM Amin, U Gupta, K Greish, ... Acta biomaterialia 43, 14-29, 2016 | 359 | 2016 |
| Tumor-targeted induction of oxystress for cancer therapy J Fang, H Nakamura, AK Iyer Journal of drug targeting 15 (7-8), 475-486, 2007 | 289 | 2007 |
| PAMAM dendrimers as promising nanocarriers for RNAi therapeutics P Kesharwani, S Banerjee, U Gupta, MCIM Amin, S Padhye, FH Sarkar, ... Materials Today 18 (10), 565-572, 2015 | 283 | 2015 |
| Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery AK Sharma, A Gothwal, P Kesharwani, H Alsaab, AK Iyer, U Gupta Drug Discovery Today 22 (2), 314-326, 2017 | 231 | 2017 |
| Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3, 4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells P Kesharwani, L Xie, S Banerjee, G Mao, S Padhye, FH Sarkar, AK Iyer Colloids and Surfaces B: Biointerfaces 136, 413-423, 2015 | 209 | 2015 |
| Doxorubicin loaded polymeric nanoparticulate delivery system to overcome drug resistance in osteosarcoma M Susa, AK Iyer, K Ryu, FJ Hornicek, H Mankin, MM Amiji, Z Duan BMC cancer 9, 1-12, 2009 | 206 | 2009 |
| Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy JM Wickens, HO Alsaab, P Kesharwani, K Bhise, MCIM Amin, RK Tekade, ... Drug discovery today 22 (4), 665-680, 2017 | 181 | 2017 |
| Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma M Susa, A Iyer, K Ryu, E Choy, F Hornicek, H Mankin, L Milane, M Amiji, ... PLOS One, 2010 | 178 | 2010 |
| Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma M Susa, AK Iyer, X Liu, E Choy, FJ Hornicek, H Mankin, L Milane, ... Cancer Research 70 (8 Supplement), 3526-3526, 2010 | 178 | 2010 |
| Advances in antibody–drug conjugates: a new era of targeted cancer therapy S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer Drug Discovery Today 22 (10), 1547-1556, 2017 | 170 | 2017 |
| Jigsaw: Large language models meet program synthesis N Jain, S Vaidyanath, A Iyer, N Natarajan, S Parthasarathy, S Rajamani, ... Proceedings of the 44th International Conference on Software Engineering …, 2022 | 167 | 2022 |
| Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy MW Amjad, P Kesharwani, MCIM Amin, AK Iyer Progress in polymer science 64, 154-181, 2017 | 164 | 2017 |
| Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer Journal of Controlled Release 274, 24-34, 2018 | 153 | 2018 |
| In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles S Ganesh, AK Iyer, F Gattacceca, DV Morrissey, MM Amiji Journal of Controlled Release, 2013 | 152 | 2013 |
Hashem O. AlsaabAssociate Professor of Pharmaceutics and Pharmaceutical Technology at Taif University, Saudi Arabia在 wayne.edu 的电子邮件经过验证
